Clinical Trials
82 trialsTRIDENT-1
Turning Point Therapeutics, Inc.
OvAR-Y
Washington University School of Medicine
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
National Cancer Institute (NCI)
Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials
Eastern Cooperative Oncology Group
iCaRe2
University of Nebraska
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Stanford University
Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations
Eli Lilly and Company
TraveraRTGx
Travera Inc
Phase II Trial of Lung Chemoemobolization
City of Hope Medical Center
Navigation Intervention for Adolescent and Young Adult Cancer Survivors
Kaiser Permanente
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Washington University School of Medicine
Vaccine Therapy and Pembrolizumab in Treating Patients With Solid Tumors That Have Failed Prior Therapy
City of Hope Medical Center
LIBRETTO-121
Eli Lilly and Company
VARTUTRACE
Var2 Pharmaceuticals
Genomic Structural Variation in Cancer Susceptibility
Memorial Sloan Kettering Cancer Center
AYAConnect
UNC Lineberger Comprehensive Cancer Center
A Study of LY3039478 in Participants With Advanced or Metastatic Solid Tumors
Eli Lilly and Company
A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Advanced Solid Tumors
GONGCHU Biotechnology Co., Ltd
A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors
Sensei Biotherapeutics, Inc.
UMBRELLA
Gustave Roussy, Cancer Campus, Grand Paris
Tempus Priority Study: A Pan-tumor Observational Study
Tempus AI
A Study of LY2880070 in Participants With Advanced or Metastatic Cancer
Esperas Pharma Inc.
ALCINA2
Institut du Cancer de Montpellier - Val d'Aurelle
IT-01
Intensity Therapeutics, Inc.
TOASTIT
Mayo Clinic
HERO
Rutgers, The State University of New Jersey
Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer
Stanford University
INJECTABL-1
Immunophotonics, Inc.
ROOT
Taproot Health
OligoRARE
European Organisation for Research and Treatment of Cancer - EORTC
Vaccine Therapy in Treating Patients With Metastatic Cancer
National Cancer Institute (NCI)
LODESTAR
pharmaand GmbH
A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)
Kineta Inc.
GASTROMO
Aesculap AG
Phase I Trial of Universal Donor NK Cell Therapy in Combination With ALT803
Case Comprehensive Cancer Center
NutriGIT
University Medicine Greifswald
GEN602
Genzada Pharmaceuticals USA, Inc.
Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients With Cancer
Roswell Park Cancer Institute
Safety Study of MGD009 in B7-H3-expressing Tumors
MacroGenics
PIONEER
SpeciCare
18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy
Stanford University
E-MOSAIC Electronic Tool to Monitor Symptoms
Swiss Cancer Institute
N1
CureOne
Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
MMS-TM
MedInnovation GmbH
Study of Pazopanib and Ixabepilone in Patients With Solid Tumors
Masonic Cancer Center, University of Minnesota
Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors
Masonic Cancer Center, University of Minnesota
Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid Tumors
Masonic Cancer Center, University of Minnesota
CT-011 and p53 Genetic Vaccine for Advanced Solid Tumors
National Institutes of Health Clinical Center (CC)
Laboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy Participants
Wake Forest University Health Sciences